Table 1. Immune status of patients... | American Society of Hematology

Table 1.

Immune status of patients before initiation of chemotherapy

	Case 1 results	Case 2 results
White blood cell count	1.62	4.83
Lymphocyte count	1.10	0.79
CD3⁺cells
%	28.8	70
Absolute count	0.32	0.52
CD19⁺ cells
%	25.8	3
Absolute count	0.28	0.02
CD16⁺CD56⁺cells
%	44.0	27
Absolute count	0.48	0.20
CD3⁺CD4⁺cells
%	10.8	36
Absolute count	0.12	0.27
CD3⁺CD8⁺cells
%	17.1	29
Absolute count	0.19	0.21
CD4s; CD4⁺CD45RA⁺CD27⁺(naive) cells
%	27.9	9
Absolute count	0.03	0.04
CD4s; CD4⁺CD45RA⁺ CD31⁺ (recent thymic emigrants), %	20.3	NA
TRECs*	Negligible	442 /10⁶ T cells
Spectratyping	4 of 24 V-β families with a Gaussian distribution	16 of 24 V-β families with a Gaussian distribution

	Case 1 results	Case 2 results
White blood cell count	1.62	4.83
Lymphocyte count	1.10	0.79
CD3⁺cells
%	28.8	70
Absolute count	0.32	0.52
CD19⁺ cells
%	25.8	3
Absolute count	0.28	0.02
CD16⁺CD56⁺cells
%	44.0	27
Absolute count	0.48	0.20
CD3⁺CD4⁺cells
%	10.8	36
Absolute count	0.12	0.27
CD3⁺CD8⁺cells
%	17.1	29
Absolute count	0.19	0.21
CD4s; CD4⁺CD45RA⁺CD27⁺(naive) cells
%	27.9	9
Absolute count	0.03	0.04
CD4s; CD4⁺CD45RA⁺ CD31⁺ (recent thymic emigrants), %	20.3	NA
TRECs*	Negligible	442 /10⁶ T cells
Spectratyping	4 of 24 V-β families with a Gaussian distribution	16 of 24 V-β families with a Gaussian distribution

Cell counts are expressed as ×10⁹/L.

The tenth percentile for TRECs in an age range of 6 to 12 years is 8534 TRECs/10⁶ T cells.